HILS

Hillstream BioPharma Inc

0.36
-0.0145 (-3.87%)

Hillstream BioPharma Inc. (HILS) Fundamentals

Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers.
SHARE INFORMATION
Market Cap$ 4,312,047
Shares Outstanding11,514,144
Float3,560,000
Percent Float30.92%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.15
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions19
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months1,264
Institutional Holdings Percent1.2%
Institutional Sold Previous 3 Months31,813
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months621,795
Insider Holdings Percent5.4
Insider Sold Previous 3 Months-
Insider Shares Owned621,795
TRADING INFO
52 Week High$ 2.65
52 Week Low$ 0.30
52 Week High Change$ -52.61
21 Day Moving Average$ 0.4088
21 Day Extended Moving Average$ 0.464451
50 Day Moving Average$ 0.6878
50 Day Extended Moving Average$ 0.63285
200 Day Moving Average$ 0.765401
200 Day Extended Moving Average$ 0.899909
10 Day Average Volume771,294
20 Day Average Volume555,194
30 Day Average Volume1,010,260
50 Day Average Volume797,062
Alpha-0.021919
Beta3.2671
Standard Deviation0.626219
R20.105710
7 Day Price Change$ 0.0044
7 Day Percent Change1.19%
21 Day Price Change$ -0.0509
21 Day Percent Change-11.97%
30 Day Price Change$ -0.3353
30 Day Percent Change-47.24%
Month to Date Price Change$ -0.0671
Month to Date Percent Change-15.19%
Quarter to Date Price Change$ -0.4171
Quarter to Date Percent Change-52.69%
180 Day Price Change$ -0.0259
180 Day Percent Change-6.47%
200 Day Price Change$ -0.1609
200 Day Percent Change-30.05%
Year to Date Price Change$ -0.0153
Year to Date Percent Change-3.93%

Hillstream BioPharma Inc. (HILS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.30
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio3.10
Leverage Ratio1.50
Quick Ratio2.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 539,039
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years4.60
Price To Book1.30
Price To Cash Flow-0.30
PE Low Last 5 Years-2.00
Price to Tangible Book1.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-102.25
Return on Equity-41.22
Return on Capital-97.53

Hillstream BioPharma Inc. (HILS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorMayer Hoffman McCann P.C.
CEORandy Milby
Employees-
Last Audit-
CIK0001861657
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1200 Route 22 East,Suite 2000
Suite 2000
Bridgewater, NJ 8807
Websitehttps://www.hillstreambio.com
Facsimile-
Telephone+1 908 955-3140
Email-


Your Recent History
NASDAQ
HILS
Hillstream..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.